Inhibition of cell proliferation in HCC-9204 hepatoma cells by a c-myc specific ribozyme

被引:0
|
作者
Jin Cheng
Jinyan Luo
Xueyong Zhang
Jialu Hu
Hongxiang Hui
Chengji Wang
Arnold Stern
机构
[1] New York University Medical Center,Department of Pharmacology
[2] Institute of Gastroenterology,Department of Biochemistry and Molecular
[3] The Second College of Xian Medical University,Biology
[4] Institute of Gastroenterology,undefined
[5] The Xijing Hospital of The Fourth Military Medical University,undefined
[6] The Fourth Military Medical University,undefined
来源
Cancer Gene Therapy | 2000年 / 7卷
关键词
Hepatoma cells; ribozyme; c-; retroviral vector.;
D O I
暂无
中图分类号
学科分类号
摘要
A ribozyme (RZ) gene targeting c-myc mRNA was synthesized and cloned. Cleavage reaction showed that cleavage of the RZ was efficient and specific. The RZ gene-containing retrovirus vector pDOR-RZ was transfected into HCC-9204 hepatoma cells, which constitutively express high levels of c-myc using Lipofectamine. Positively transfected cells were selected using G418. In situ hybridization showed that both pDOR-RZ and pDOR vectors had been integrated into the chromosome of HCC-9204 cells. Dot blot hybridization indicated that expression of the RZ was only evident in pDOR-RZ-transfected HCC-9204 cells. Avidin-biotin complex enzyme-linked immunosorbent assay showed that c-myc expression was down-regulated. Chromatin aggregation into compact masses, cytoplasmic vacuole degeneration, and blurring of cytoplasm structure were observed by transmission electron microscopy in HCC-9204-RZ cells. These results suggest that the use of a c-myc mRNA cleaving enzyme could be most effective in tumor cells that are highly proliferative and constitutively express high levels of c-myc.
引用
收藏
页码:407 / 412
页数:5
相关论文
共 50 条
  • [41] Defining the specific physiological requirements for c-Myc in T cell development
    Nataki C. Douglas
    Harris Jacobs
    Alfred L. M. Bothwell
    Adrian C. Hayday
    Nature Immunology, 2001, 2 : 307 - 315
  • [42] HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation
    Gordan, John D.
    Thompson, Craig B.
    Simon, M. Celeste
    CANCER CELL, 2007, 12 (02) : 108 - 113
  • [43] Taurodeoxycholate increases intestinal epithelial cell proliferation through c-myc expression
    Yamaguchi, J
    Toledo, A
    Bass, BL
    Celeste, FA
    Rao, JN
    Wang, JY
    Strauch, ED
    SURGERY, 2004, 135 (02) : 215 - 221
  • [44] Modulation of cell proliferation by the over-expression of c-myc gene.
    Ifandi, V
    Al-Rubeai, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U129 - U129
  • [45] MODULATION OF C-MYC GENE-EXPRESSION BY EXTRACELLULAR STIMULI IN RAT HEPATOMA-CELLS
    MORIMURA, S
    KATO, K
    TASHIRO, F
    UENO, Y
    JAPANESE JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 60 (02): : 51 - 56
  • [46] Prox1 Suppresses the Proliferation of Breast Cancer Cells via Direct Inhibition of c-Myc Gene Expression
    Michail, Artemis
    Gkikas, Dimitrios
    Stellas, Dimitris
    Kaltezioti, Valeria
    Politis, Panagiotis K.
    CELLS, 2023, 12 (14)
  • [47] Induction of hepatoma cell apoptosis by c-myc requires zinc and occurs in the absence of DNA fragmentation
    Xu, J
    Xu, Y
    Nguyen, Q
    Novikoff, PM
    Czaja, MJ
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1996, 270 (01): : G60 - G70
  • [48] Comparative analysis of the structure and function of the chicken c-myc and v-myc genes: v-myc is a more potent inducer of cell proliferation and apoptosis than c-myc
    Petropoulos, CJ
    Givol, I
    Hughes, SH
    ONCOGENE, 1996, 12 (12) : 2611 - 2621
  • [49] miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells
    Hantao Wang
    Fuao Cao
    Xu Li
    Hua Miao
    Jifu E
    Junjie Xing
    Chuan-gang Fu
    BMC Cancer, 15
  • [50] miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells
    Wang, Hantao
    Cao, Fuao
    Li, Xu
    Miao, Hua
    E, Jifu
    Xing, Junjie
    Fu, Chuan-gang
    BMC CANCER, 2015, 15